About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Tamiflu Still Number One In Treatment Of Bird Flu

by Medindia Content Team on August 25, 2007 at 6:10 PM
Font : A-A+

Tamiflu Still Number One In Treatment Of Bird Flu

In updated guidance from the World Health Organization, Tamiflu (oseltamivir) remains the primary recommended antiviral of choice in treating patients infected with H5N1. Experts believe that a human influenza pandemic is imminent and could be triggered by the highly pathogenic H5N1 strain, which, as of Aug. 16 2007, has infected 321 humans, causing 194 deaths worldwide.

"Experiences clearly show that to reduce mortality patients should receive treatment with oseltamivir as early as possible, but treatment remains effective even when patients present late," commented Professor John Oxford, Professor of Virology at St Bartholomew's and the Royal London Hospital, "H5N1 has proven to be an extremely virulent virus in humans and in some countries we have seen the need to use higher and longer doses of oseltamivir to gain maximum benefit."

Advertisement

The latest advice is based on evidence presented to the WHO by experts in countries that have reported human cases of bird flu. Tamiflu is the only neuraminidase inhibitor to have been used in the management of human cases of H5N1 and is the only antiviral strongly recommended for treatment of H5N1 infected patients by the WHO.

With this latest evidence WHO recommends:

Standardising care and promptly sharing clinical and treatment information to improve understanding of the disease and identify appropriate therapy.
Advertisement

Tamiflu remaining the primary antiviral treatment both early and late in the infection as there is evidence of prolonged replication with H5N1.

Modified Tamiflu treatment regimens - higher and longer dosing may be necessary given the virulence of some forms of H5N1 seen recently.

Possible combination therapy with adamantanes (case by case basis), particularly in patients with pneumonia or progressive disease.

The guidance also states that inhaled zanamivir has not been studied in human H5N1 illness and that the adequacy of inhaled zanamivir delivery in patients with serious lower respiratory tract or extra pulmonary disease is a major concern. Ongoing modifications will be made to the WHO guidance based on continual research findings.

During the clinical development programme Roche carried out studies looking at higher doses of Tamiflu. The safety profile at these higher doses was supportive of further investigation A high versus standard dosage study has recently started in patients with severe influenza, both H5N1 and seasonal, in conjunction with the National Institutes of Health (NIH), to determine which is the most effective dose in severe disease.

WHO coordinates the global response to human cases of H5N1 avian influenza and tracks the corresponding threat of an influenza pandemic, providing access to both technical guidelines and information useful for the general public.

Tamiflu is an oral neuraminidase inhibitor that is active against all strains of influenza A and B tested. More than 80 governments worldwide are now stockpiling Tamiflu in preparation for a pandemic and many global businesses are in discussions with Roche and are now stockpiling for their employees and their families in line with local laws and regulations.

Source: Eurekalert
LIN/B
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Turmeric: Magic Ingredient to Keep you Healthy in Winter
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Bird Flu Flu Swine Flu 

Recommended Reading
Bird Flu
Bird flu (avian influenza/avian flu) is a disease caused by an influenza virus (H5N1) that ......
Tamiflu 30 Mg and 45 Mg Capsules Approved by FDA
Roche announced today that the U.S. FDA has approved a supplemental new drug application to market ....
“Oral Anti Viral Tamiflu” –A Cost Effective Treatment
Treatment with the oral antiviral Tamiflu (oseltamivir) and prophylaxis for people exposed to ......
Swine Flu
Swine flu, a type of influenza caused by a new strain of the H1N1 Type A influenza virus has origina...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use